Hill, C. et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506–514 (2014).

Article  PubMed  Google Scholar 

Liu, H. et al. A multicellular self-organized probiotic platform for oral delivery enhances intestinal colonization. Nat. Commun. 16, 7060 (2025).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Konstantinov, S. R. et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl Acad. Sci. USA 105, 19474–19479 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asare, P. T. et al. Reuterin demonstrates potent antimicrobial activity against a broad panel of human and poultry meat Campylobacter spp. isolates. Microorganisms 8, 78 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rutter, J. W. et al. A bacteriocin expression platform for targeting pathogenic bacterial species. Nat. Commun. 15, 6332 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamada, N. et al. Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. Infect. Immun. 76, 214–220 (2008).

Article  CAS  PubMed  Google Scholar 

Baralić, K., Živančević, K., Bozic, D. & Đukić-Ćosić, D. Probiotic cultures as a potential protective strategy against the toxicity of environmentally relevant chemicals: state-of-the-art knowledge. Food Chem. Toxicol. 172, 113582 (2023).

Article  PubMed  Google Scholar 

O’Toole, P. W., Marchesi, J. R. & Hill, C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 2, 17057 (2017).

Article  PubMed  Google Scholar 

Suez, J., Zmora, N., Segal, E. & Elinav, E. The pros, cons, and many unknowns of probiotics. Nat. Med. 25, 716–729 (2019).

Article  CAS  PubMed  Google Scholar 

Baião, R. et al. Multispecies probiotic administration reduces emotional salience and improves mood in subjects with moderate depression: a randomised, double-blind, placebo-controlled study. Psychol. Med. 53, 3437–3447 (2023).

Article  PubMed  Google Scholar 

Asghari, K. M. et al. The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial. Sci. Rep. 13, 18577 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gibson, G. R. et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 14, 491–502 (2017).

Article  PubMed  Google Scholar 

Hutkins, R. et al. Classifying compounds as prebiotics — scientific perspectives and recommendations. Nat. Rev. Gastroenterol. Hepatol. 22, 54–70 (2025).

Article  PubMed  Google Scholar 

Swanson, K. S. et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat. Rev. Gastroenterol. Hepatol. 17, 687–701 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Lewis, Z. T. et al. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr. Res. 79, 445–452 (2016).

Article  CAS  PubMed  Google Scholar 

MarketsandMarkets. Probiotics Market Report (Global Forecast to 2029) (MarketsandMarkets, 2025).

McFarland, L. V. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J. Gastroenterol. 16, 2202–2222 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Li, M. et al. Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery. Biomaterials 309, 122584 (2024).

Article  CAS  PubMed  Google Scholar 

Allegretti, J. R. et al. Safety and efficacy of fecal microbiota, live-jslm (REBYOTA®), for the prevention of recurrent Clostridioides difficile infection in participants with inflammatory bowel disease in PUNCH CD3-OLS. Inflamm. Bowel Dis. 31, 2112–2122 (2025).

Article  PubMed  PubMed Central  Google Scholar 

Rosenberg, J. & Ritter, T. Practical use of fecal microbiota spores, live-brpk (formerly SER-109): an oral therapeutic for the prevention of recurrent Clostridioides difficile infection. Expert Rev. Antiinfect. Ther. 21, 687–690 (2023).

Article  CAS  Google Scholar 

Feuerstadt, P. et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. N. Engl. J. Med. 386, 220–229 (2022).

Article  CAS  PubMed  Google Scholar 

Khanna, S. et al. Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a Bayesian primary analysis for the prevention of recurrent Clostridioides difficile infection. Drugs 82, 1527–1538 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peled, J. U. et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 382, 822–834 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rashidi, A. et al. Randomized double-blind phase II trial of fecal microbiota transplantation versus placebo in allogeneic hematopoietic cell transplantation and AML. J. Clin. Oncol. 41, 5306–5319 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Veiga, P., Suez, J., Derrien, M. & Elinav, E. Moving from probiotics to precision probiotics. Nat. Microbiol. 5, 878–880 (2020).

Article  PubMed  Google Scholar 

Zmora, N. et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174, 1388–1405.e21 (2018).

Article  CAS  PubMed  Google Scholar 

Hernández Medina, R. et al. Machine learning and deep learning applications in microbiome research. ISME Commun. 2, 98 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Marcos-Zambrano, L. J. et al. Applications of machine learning in human microbiome studies: a review on feature selection, biomarker identification, disease prediction and treatment. Front. Microbiol. 12, 634511 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, N. & Guo, X. The gut microbiota and host immunity synergistically orchestrate colonization resistance. Gut Microbes 18, 2611545 (2026).

Article  PubMed  PubMed Central  Google Scholar 

Merenstein, D. J. et al. Is there evidence to support probiotic use for healthy people? Adv. Nutr. 15, 100265 (2024).

Article  PubMed  PubMed Central  Google Scholar 

McFarland, L. V., Evans, C. T. & Goldstein, E. J. C. Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis. Front. Med. 5, 124 (2018).

Article  Google Scholar